SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-056395
Filing Date
2024-05-02
Accepted
2024-05-02 16:15:12
Documents
2
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2413094-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2413094-1_3seq1.xml 3 3177
2 EXHIBIT 24 tm2413094d1_ex24.htm EX-24 9723
  Complete submission text file 0001104659-24-056395.txt   14306
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
Mirza Nadeem Q. (Reporting) CIK: 0002021015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39069 | Film No.: 24908463